BSE: 543520
Global Longlife Hospital and R
A BSE-listed hospital and research company that has effectively ceased operations, with FY26 revenue collapsing to near zero from the prior year. The board is seeking shareholder approval to change its name to Kanzi/Asahi/Siddhaa Enterprise Limited and amend the object clause to exit healthcare and enter food commodities, agriculture produce, textiles, apparel, bullion (gold/silver) trading, and commodity exchange businesses. No specific hospital operating details such as number of beds, departments, or services are disclosed in the filings. The promoter Managing Director, Dhruv Jani, brings prior experience in the cotton and oil business, which is relevant to the proposed trading pivot. The company ended FY26 with a net loss of Rs. 171.95 lakhs versus a Rs. 19.87 lakh profit a year earlier, on share capital of Rs. 1,050 lakhs. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Hospital and healthcare services, Food commodities, agriculture produce, textiles, apparel, bullion trading and commodity exchange (proposed). Listed entity in operational transition, legacy hospital line near-zero, proposed pivot to commodity and textile trading
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · standalone | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 33 | 24 | 14 | 1 | 0 |
| EBITDA (ex other income) | — | — | — | — | — |
| margin % | — | — | — | — | — |
| Owners' profit | — | — | — | — | — |
| EPS, as reported (₹) | 5.11 | 1.79 | (2.08) | 0.19 | 1.64 |
| ROE % · ROCE % | — · 35.2 | — · 4.6 | — · (5.1) | — · 1.4 | — · (4.2) |
| Debt / equity (x) | — | — | — | — | — |
| Cash from operations | 9 | (40) | (5) | 12 | (5) |
| Capex | — | — | — | (0) | 0 |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY23 | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 12 | 12 | 1 | 1 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 2 | (4) | 1 | (1) | (1) | (0) |
| Net profit | — | — | — | — | — | — | — | — |
| EPS (₹) | 0.72 | 1.05 | 0.98 | (3.06) | 1.18 | 0.99 | 1.26 | 0.38 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 1,10,237 | 52.8 | 11.05 | 29.2 | 20.1 | 16.6 | 19.0 | 16.2 |
| MAX HEALTHCARE INS LTD | 85,003 | 58.3 | 7.91 | 37.3 | 13.4 | 11.1 | 27.3 | 27.0 |
| FORTIS HEALTHCARE LTD | 57,603 | 55.0 | 5.66 | 28.4 | 10.5 | 9.7 | 17.8 | 22.0 |
| ASTER DM QUALITY CARE LTD | 35,077 | 109.5 | 7.26 | 35.8 | 8.8 | 8.5 | (11.6) | 14.3 |
| NARAYANA HRUDAYALAYA LTD. | 34,337 | 41.8 | 7.56 | 23.1 | 17.8 | 9.2 | 25.0 | 18.8 |
| GLOBAL HEALTH LIMITED | 34,241 | 61.5 | 8.59 | 34.7 | 13.9 | 13.5 | — | 23.7 |
| KRISHNA INST OF MED SCI L | 28,892 | 134.9 | 11.29 | 39.3 | 9.5 | 5.1 | 24.0 | 20.3 |
| DR AGARWALS HEALTH CARE L | 14,804 | 99.6 | 6.98 | 24.2 | 7.9 | 7.1 | — | 28.8 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 3.4 | 42.4 | 1 of 30 | 100% |
| ROCE | (4.2) | 10.9 | 29 of 30 | 3% |
| Revenue growth | (100.0) | 20.2 | 23 of 23 | 0% |
| Market cap | 13 | 2699 | 29 of 30 | 3% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Oct 2026 · Notice of First EGM and e-voting details published in newspapers | compliance | minimal | — | — |
| 7 Oct 2026 · First EGM on Oct 30 to ratify Chartered Accountant's certificate for name change | board shareholder meetings | low | — | — |
| 3 Oct 2026 · Board Approves First EOGM of FY27 on October 30, 2026 | board shareholder meetings | low | — | — |
| 30 Sept 2026 · Trading window closed from Oct 1, 2026 until H1 results announcement | compliance | minimal | — | — |
| 28 Sept 2026 · Company renamed to Asahi Enterprise Limited | general | medium | — | — |
| 26 Sept 2026 · Non-promoter HUF acquires 5.09% stake via open market | ownership changes | medium | — | — |
| 25 Aug 2026 · Hospital firm broadens objects clause to food and textile businesses | general | medium | — | — |
| 19 Aug 2026 · Trade Pulse Broking raises stake in Global Longlife to 7.31% via open market | ownership changes | high | — | — |
| 13 Aug 2026 · Promoter Dhruv Jani sells nearly entire 6.88 percent stake | ownership changes | high | — | — |
| 10 Aug 2026 · Promoter Dhruv Sureshkumar Jani sells 9.52% stake in Global Longlife Hospital | ownership changes | high | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.